MedTrace is developing the MT-100 chemistry system and
aQuant analytical software which helps doctors diagnose
heart patients faster and more accurately utilizing
radioactive water (O15-H2O) and medical imaging.
What do we offer? Project Picture
The MT-100 system is an automated chemistry lab
producing and injecting radioactive water. aQuant is
analytical software processing the data of a PET scan into
For a PET-scanner to visualize and quantify the blood flow
of a patient, a tracer needs to be injected. Radioactive
water gives the most accurate results in comparison to any
other PET tracers. Until now radioactive water has only
been utilized in medical research. By medical imaging and
automatizing the delicate procedure of producing and
injecting radioactive water, MedTrace offers the gold
standard of tracers for routine examinations.
¼ deaths in the world is caused by heart diseases, and this
share is increasing. Health care systems around the world
are under pressure to improve diagnostics of heart
patients while also lowering the cost. MT-100 is ideal for
doing exactly that.
What differentiates us?
The MT-100 system is unique because it will be the world’s first regulatory approved automated water system
allowing bedside production and injection of the gold standard tracer for blood flow exams. aQuant is unique
because it allows visualization of the blood flow in combination with quantitative flow data.
What do we look for at the Medico Bazar?
MedTrace is looking to expand our academic network within DTU and to get in contact with professors and master
students for discussions on future project collaboration possibilities. We are also looking to discuss possible
recruitments for Q3-4 2018 within R&D, software and Regulatory Affairs.
MedTrace A/S – CVR 36497661
Martin Stenfeldt, CEO
Gotlandsvej 5, 5700 Svendborg (Offices at ScionDTU in Lyngby)
+45 28 10 41 49